Skip to content

Feasibility of ejection fraction measurement with Gallium-68-citrate PET/CT (EF-PET)

Feasibility of ejection fraction measurement with Gallium-68-citrate PET/CT (EF-PET) - EF-PET

Status
Active, not recruiting
Phases
Phase 2
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34569
Enrollment
20
Registered
2010-05-31
Start date
2010-10-01
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degradation of heart function loss of left ventricular ejection fraction.

Interventions

None listed

Sponsors

Antoni van Leeuwenhoek Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with malignant disease of any kind - Referred for LVEF measurement according to clinical indications - Willing to undergo additional EF-PET on the same day - Signed informed consent

Exclusion criteria

Exclusion criteria: - Age

Design outcomes

Primary

MeasureTime frame
Feasibility of the EF-PET technique, yes or no.

Secondary

MeasureTime frame
To optimize the procedure To compare the technique with the current standard of planar LVEF measurement.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)